Xeris Biopharma Holdings Inc. buy SVB Leerink LLC
Start price
10.03.25
/
50%
€4.21
Target price
10.03.26
€5.52
Performance (%)
17.02%
End price
11.03.26
€4.92
Summary
This prediction ended on 11.03.26 with a price of €4.92. The prediction had a final performance of 17.02%. SVB_Leerink_LLC has a follow-up prediction for Xeris Biopharma Holdings Inc. where he still thinks Xeris Biopharma Holdings Inc. is a Buy. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | 2.477% | 2.477% | 13.940% |
| iShares Core DAX® | -1,28 % | 4,21 % | 7,08 % |
| iShares Nasdaq 100 | -3,34 % | -1,74 % | 26,18 % |
| iShares Nikkei 225® | -4,29 % | -1,62 % | 44,32 % |
| iShares S&P 500 | -2,31 % | -0,10 % | 20,82 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target raised by analysts at Leerink Partners from $5.00 to $6.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten
Current prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€6.61
22.08.25
22.08.25
€7.75
22.08.26
22.08.26
12.65%
21.08.26
21.08.26
